Table 1 Characteristics of triple negative breast cancer cases and controls [matched on year of study entry, age at entry, days blood was in the post before processing, and cancer-free years in the study (time at risk)].

From: DNA methylation of the long intergenic noncoding RNA 299 gene in triple-negative breast cancer: results from a prospective study

Characteristic

Cases n (%)

Controls n (%)

Totala

154

159

Age at study entry [mean (range), years]

52.1 (24–80)

52.1 (22–81)

Year of study entry

2004–2010

2004–2009

Age at blood draw [mean (range), years]

52.1 (24–80)

52.2 (22–81)

Age at diagnosis date [mean (range), years]

56.7 (26–87)

Blood draw to diagnosis [mean (range), years]

4.6 (0–10)

Days blood in post

0–1

116 (75.3)

120 (75.5)

2

11 (7.1)

11 (6.9)

3+

27 (17.5)

28 (17.6)

Smoking status

Never

94 (61.0)

94 (59.1)

Ex-smoker

51 (33.1)

53 (33.3)

Current

9 (5.8)

12 (7.6)

  1. TNBC triple negative breast cancer.
  2. aIncluding twelve participants with prior cancer (that is not breast cancer).